These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effects of botulinum toxin on ocular tissue. Smith H Nurs Times; 1995 Jan 25-31; 91(4):41-3. PubMed ID: 7862573 [TBL] [Abstract][Full Text] [Related]
5. NIH consensus panel recommends a range of adjuvant therapies for women with breast cancer. J Am Coll Surg; 2001 Feb; 192(2):288. PubMed ID: 11220730 [No Abstract] [Full Text] [Related]
6. NIH consensus panel advocates increased access to treatment for opiate addiction. Morey SS Am Fam Physician; 1998 Sep; 58(3):786, 789. PubMed ID: 9750544 [No Abstract] [Full Text] [Related]
7. The current use of botulinum toxin. Mahant N; Clouston PD; Lorentz IT J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658 [TBL] [Abstract][Full Text] [Related]
11. The use of botulinum toxin in the treatment of refractory overactive bladder. Mucksavage P; Smith AL; Moy ML Ostomy Wound Manage; 2006 Dec; 52(12):28, 30, 32-3. PubMed ID: 17219700 [No Abstract] [Full Text] [Related]
12. Botulinum toxins: pharmacology and its current therapeutic evidence for use. Panicker JN; Muthane UB Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921 [TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin (BoNT) : Short form of a European consensus panel report regarding recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions]. Schulte-Baukloh H Urologe A; 2010 Jan; 49(1):56-63. PubMed ID: 19876612 [TBL] [Abstract][Full Text] [Related]
14. [Consensus conferences: instructions for their use]. Liberati A Recenti Prog Med; 1996 Feb; 87(2):49-50. PubMed ID: 8725079 [No Abstract] [Full Text] [Related]
15. Pearls and pitfalls in the therapeutic use of botulinum toxin. Smith AG Semin Neurol; 2004 Jun; 24(2):165-74. PubMed ID: 15257513 [TBL] [Abstract][Full Text] [Related]
16. [The value of consensus conferences]. RodrĂguez Artalejo F; Banegas JR Med Clin (Barc); 1992 Jun; 99(3):103-5. PubMed ID: 1630196 [No Abstract] [Full Text] [Related]
17. [Other uses for botulinum toxin in neurology]. Vial C; Bouhour F; de Saint Victor JF Rev Neurol (Paris); 2003 Sep; 159(8-9):814-8. PubMed ID: 13679728 [No Abstract] [Full Text] [Related]
18. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference. South Med J; 2001 Jun; 94(6):569-73. PubMed ID: 11440324 [No Abstract] [Full Text] [Related]
19. The NIH Consensus Development Program. The evolution of guidelines. Ferguson JH Int J Technol Assess Health Care; 1996; 12(3):460-74. PubMed ID: 8840666 [TBL] [Abstract][Full Text] [Related]
20. Panelists' views of 68 NIH consensus conference. Ferguson JH; Sherman CR Int J Technol Assess Health Care; 2001; 17(4):542-58. PubMed ID: 11758298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]